tiprankstipranks

SAURABH SAHA Insider Profile

11 Followers
SAURABH SAHA, CEO, Director at Centessa Pharmaceuticals, holds 82.02K shares in Clarivate (Ticker: CLVT), holds 369.02K shares in Centessa Pharmaceuticals (Ticker: CNTA). Most recently, SAURABH SAHA Bought ― shares of Clarivate on Mar 05, 2025 for an estimated value of 254.08K.
tipranks
SAURABH SAHA

SAURABH SAHA
Centessa Pharmaceuticals (CNTA)
CEO, Director

Ranked #69,210 out of 100,956 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

-11.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
94.37%
5.63%
A breakdown of SAURABH SAHA's holdings

Insider Roles

Centessa Pharmaceuticals
(CNTA)
CEO, Director
Clarivate
(CLVT)
Director
Roles that SAURABH SAHA holds in companies

Most Profitable Insider Trade

Stock:
Clarivate
(CLVT)
Rating:Informative Sell
Date:Sep 04, 2024 - Today
Return:+39.10%
The most profitable trade made by SAURABH SAHA

SAURABH SAHA's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Centessa Pharmaceuticals
Feb 20, 2025
CEO, Director
Uninformative Sell
876.08K
$5.99M
Clarivate
Mar 05, 2025
Director
Informative Buy
254.08K
$357.59K
List of latest transactions for each holding click on a transaction to see SAURABH SAHA's performance on stock

SAURABH SAHA insider profile FAQ

What is the percentage of profitable transactions made by SAURABH SAHA?
The percentage of profitable transactions made by SAURABH SAHA is 60%.
    What is the average return per transaction made by SAURABH SAHA?
    The average return per transaction made by SAURABH SAHA is -11.30%.
      What stocks does SAURABH SAHA hold?
      SAURABH SAHA holds: CNTA, CLVT stocks.
        What was SAURABH SAHA’s latest transaction?
        SAURABH SAHA latest transaction was an Informative Buy of $254.08K.
          What was SAURABH SAHA's most profitable transaction?
          SAURABH SAHA’s most profitable transaction was an Informative Sell of CLVT stock on September 4, 2024. The return on the trade was 39.10%.
            What is SAURABH SAHA's role in Centessa Pharmaceuticals?
            SAURABH SAHA's role in Centessa Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.